Significance of angiopoietin-2 as a serum marker for hepatocellular carcinoma

Serum levels of ace, angiotensin II and CA19-9 in Egyptian patients with liver cirrhosis and in hepatocellular carcinoma

Telomerase activity in peripheral blood in chronic hepatitis and hepatocellular carcinoma

Evaluation of tumor marker (PIVAK-II) in patients with positive HCV infection with and without cirrhosis complicated and uncomplicated with hepatocellular carcinoma

Squamous cell carcinoma antigen : A novel tumor marker for hepatocellular carcinoma

Significance of serum chromogranin-A in patients withliver cirrhosis and hepatocellular carcinoma

Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

Diagnostic value of serum level of soluble tumor necrosis factor receptor II in patients with chronic hepatitis C virus infection and hepatocellular carcinoma

Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

Significance of hepatocyte growth factor (HGF) concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinoma